Comparative Study
Journal Article
Add like
Add dislike
Add to saved papers

Prognostic factors in carpal tunnel syndrome treated with a corticosteroid injection.

Muscle & Nerve 2011 November
INTRODUCTION: Symptoms often return in patients with carpal tunnel syndrome (CTS) who are treated with a local corticosteroid injection. We aimed to determine prognostic factors for a successful long-term outcome.

METHODS: We prospectively followed 113 patients who received an injection for CTS. Clinical, electrophysiological, and ultrasonographic tests were done at baseline, and clinical outcome was evaluated after 1, 3, 6, and 12 months. The primary outcome measure for success was no need for additional treatment (e.g., surgery) within 1 year.

RESULTS: After 1 month, most patients improved, but after 12 months 67.4% had surgery. Patients with a successful outcome had a lower median nerve ultrasonographic cross-sectional area (CSA) at the pisiform bone, a lower swelling ratio, and a lower symptom severity score.

CONCLUSIONS: Less pronounced median nerve swelling measured by ultrasonography may indicate a less severe stage of CTS, which is more likely to respond to treatment with a corticosteroid injection.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app